Skip to main content

Cammack, Kamlager-Dove, and Christina Perri Launch Bipartisan Effort to Expand Prenatal Screening to Prevent Miscarriages & Stillbirths

September 9, 2025

Washington, D.C. — Today, U.S. Representatives Kat Cammack (R-FL) and Sydney Kamlager-Dove (D-CA) introduced a bipartisan resolution to expand prenatal screening for Antiphospholipid Syndrome (APS), a treatable blood clotting disorder linked to miscarriages, stillbirths, and other pregnancy complications.

This effort builds on the advocacy of multi-platinum recording artist Christina Perri, whose personal experience with pregnancy loss due to undiagnosed APS has fueled her mission to ensure other families do not endure similar tragedies.

“For too long, women and families have endured the heartbreak of miscarriage and stillbirth without answers—losses that, in many cases, could have been prevented with early detection. By expanding prenatal screening for APS, we have the chance to save lives, protect mothers and babies, and spare families untold grief,” said Congresswoman Cammack. “I am proud to partner with Congresswoman Kamlager-Dove on this bipartisan effort, and deeply grateful to Christina Perri for transforming her personal tragedy into a mission to protect others.”

“Anyone who has experienced the heartbreak of even a single miscarriage or stillbirth knows that one is already too many. Yet, current medical guidelines only recommend testing for Antiphospholipid Syndrome after multiple pregnancy losses—this is unacceptable,” said Congresswoman Kamlager-Dove. “Failing to include APS in routine prenatal testing isn’t just a medical oversight, it’s a glaring failure of our maternal healthcare system. This is not complicated—it’s a matter of basic human decency and a call for smarter, more compassionate healthcare policy.” 

"I'm so glad my story has a happy ending with my double rainbow baby Pixie. But let's make a change so no one has to have my story again. Let's not get angry, let's get inspired," said Christina Perri. "This isn't about the past. This is about giving a purpose to my Rosie's life. It's about saving babies and helping all other women, families, and kids avoid the anguish that I experienced. I am here to raise awareness about a blood test that can determine this treatable autoimmune disease.

“APS is a treatable disorder, yet without screening, it can lead to heartbreaking losses," said Congressman Greg Landsman (D-OH). "Our bipartisan resolution is a simple fix that would improve birth outcomes and better protect mothers and their babies.”

“Too many families know the heartbreak of pregnancy loss. Often, this heartbreak is met without answers,” said Congresswoman Young Kim (R-CA). “Expanding access to prenatal screening for APS is a critical, commonsense step we can take to give moms peace of mind, help doctors provide the best care, and prevent tragedies that could have been avoided. I’m proud to join Reps. Cammack and Kamlager-Dove in this bipartisan effort to provide clarity for families and raise greater awareness about the importance of expanding access to testing for APS."

"I'm proud to stand with my colleagues in working to improve prenatal screening for all women,” said Congresswoman Sheila Cherfilus-McCormick (D-FL). "In Florida, over 20% of women received no or inadequate prenatal care in 2023. Early detection of complications like antiphospholipid syndrome can save both mothers and babies. This resolution helps ensure that every woman, no matter where she lives, has access to the care she needs for a healthy pregnancy and future."

“While it was a huge milestone to get my Maternal and Child Health Stillbirth Act signed into law last year, we have much more work to do to improve care for expecting mothers and prevent stillbirth and miscarriages. I will continue to be a strong voice for mothers in Congress, and work to ensure all expecting mothers have access to the care they need," said Congresswoman Ashley Hinson (R-IA)."That is also why I am proud to join my colleagues on this bipartisan House resolution to support prenatal screening for Antiphospholipid Syndrome. Thank you to Christina Perri, Rep. Cammack, and Rep. Kamlager-Dove for your advocacy and leadership!”

Christina Perri’s Advocacy
Best known for her multi-platinum hit “A Thousand Years” from The Twilight Saga—one of the most popular wedding songs of the last decade—Perri has become a leading national voice for expanded prenatal screening. In 2020, she lost her daughter Rosie at 38 weeks and later learned she had APS. If detected early, APS can often be safely managed with simple blood-thinning medications.

Background on APS
Antiphospholipid Syndrome (APS) is an autoimmune disorder in which antibodies trigger dangerous blood clots. During pregnancy, APS can cause miscarriage, stillbirth, and severe complications. The condition affects at least 1 in 2,000 pregnancies, though experts believe it is widely underdiagnosed. Critically, APS-related pregnancy loss is often preventable with early detection and treatment.

Currently, most medical guidelines only recommend testing after multiple pregnancy losses. Yet the blood test costs less than $1,000—far less than the $15,000 average cost of post-miscarriage procedures. The resolution calls for APS screening to become a standard part of prenatal care, an initiative that could save lives, prevent heartbreak, and reduce healthcare costs nationwide.

Watch today's press conference here

###